In response to this need, Zhou et al. developed nanoprobes capable of emitting blue, green, and red single-band light, which were used to enable simultaneous in situ molecular imaging and quantitative detection of ER, PR, and HER2 in BC cells and tissues (Figure 12A). The gene discussed is ERBB2; the disease is breast cancer.